The company said, “VSee Health (VSEE), leveraging its newly secured FedRAMP Moderate authorization to deliver secure, scalable telehealth services to federal agencies and beyond. In a bold step forward, VSee is integrating advanced robotic assistance into intensive care units, enabling remote clinicians to monitor and intervene in real-time – potentially transforming critical care delivery. Building on its revenue growth and balance sheet strengthening, VSee’s innovations align perfectly with the exploding U.S. telehealth market, projected to hit $52.76B in 2025 and grow at a 23.84% CAGR through 2034…The company’s platform now supports omni-channel visits, plug-and-play remote exams, and seamless EHR integrations, making it the go-to solution for health systems, payers, and federal entities alike. This dual-pronged strategy – FedRAMP readiness plus ICU robotics – comes as VSee reports a 150% year-over-year increase in enterprise deployments, with new partnerships in the pipeline that could add millions in recurring revenue by Q2 2026.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VSEE:
- VSee Health engages Philippine health leaders in Southeast Asia expansion effort
- VSee Health secures three-year platform services agreement
- VSee Health Enters Warrant Exchange Agreement
- VSee Health Announces 2025 Annual Stockholders Meeting
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
